1. Home
  2. CDLX vs NMTC Comparison

CDLX vs NMTC Comparison

Compare CDLX & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cardlytics Inc.

CDLX

Cardlytics Inc.

HOLD

Current Price

$5.16

Market Cap

30.2M

Sector

Technology

ML Signal

HOLD

Logo NeuroOne Medical Technologies Corporation

NMTC

NeuroOne Medical Technologies Corporation

HOLD

Current Price

$3.20

Market Cap

29.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDLX
NMTC
Founded
2008
2009
Country
United States
United States
Employees
224
N/A
Industry
Computer Software: Programming Data Processing
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.2M
29.2M
IPO Year
2018
2010

Fundamental Metrics

Financial Performance
Metric
CDLX
NMTC
Price
$5.16
$3.20
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
$2.25
$11.90
AVG Volume (30 Days)
324.6K
25.8K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
50.13
80.43
EPS
N/A
N/A
Revenue
$233,273,000.00
$9,097,692.00
Revenue This Year
N/A
N/A
Revenue Next Year
$8.82
$31.90
P/E Ratio
N/A
N/A
Revenue Growth
N/A
163.47
52 Week Low
$0.55
$0.55
52 Week High
$6.40
$5.40

Technical Indicators

Market Signals
Indicator
CDLX
NMTC
Relative Strength Index (RSI) 81.03 40.60
Support Level $0.83 $0.69
Resistance Level $6.40 $4.87
Average True Range (ATR) 0.41 0.21
MACD 0.30 -0.04
Stochastic Oscillator 79.49 27.69

Price Performance

Historical Comparison
CDLX
NMTC

About CDLX Cardlytics Inc.

Cardlytics Inc is a commerce media platform that is designed to make commerce smarter and rewarding for everyone. At the core of its commerce media platform is the financial media network that it runs within its partners' digital channels, which includes online and mobile applications (the Cardlytics platform). Additionally, it operates an identity resolution platform that utilizes point-of-sale (POS) data, including product-level purchase data, to enable marketers to perform analytics and targeted loyalty marketing and also measure the impact of their marketing (the Bridg platform). It operates in three segments: the Cardlytics platform in the U.S.; the Cardlytics platform in the U.K.; and the Bridg platform. The majority of the revenue is derived from the Cardlytics platform.

About NMTC NeuroOne Medical Technologies Corporation

NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with diagnostic and stimulation capabilities. It develops thin film electrode technology for various recording and therapeutic applications, crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company operates in one segment, developing and commercializing products for neuromodulation, cEEG, and sEEG recording, monitoring, ablation, and brain stimulation, with revenue from Evo Cortical, Evo sEEG, and OneRF Ablation System.

Share on Social Networks: